OOS – Page 36 – Pharma.Tips

FBD drying inconsistency during inspection readiness – inspection risk analysis

Addressing FBD Drying Inconsistencies in Inspection-Ready Environments In the pharmaceutical manufacturing landscape, fluidized bed dryers (FBD) play a critical role in ensuring product quality through effective moisture removal during granulation…

FBD drying inconsistency during validation – CAPA and control strategy gap

Addressing Inconsistencies in FBD Drying during Validation Failures in Fluid Bed Dryer (FBD) performance during validation phases can lead to significant quality risks and regulatory scrutiny in pharmaceutical manufacturing. Inconsistent…

Inadequate end-point detection after scale-up – process vs equipment root cause

Identifying and Resolving Inadequate End-Point Detection after Scale-Up in Pharmaceutical Manufacturing In the highly regulated world of pharmaceutical manufacturing, inadequate end-point detection during scale-up poses serious challenges that can affect…

RMG torque fluctuation during drying phase – process vs equipment root cause

Addressing RMG Torque Fluctuation During the Drying Phase: Practical Insights In the realm of pharmaceutical manufacturing, RMG (Rapid Mixer Granulator) machines are pivotal for achieving uniform granulation. Yet, fluctuations in…

FBD drying inconsistency during wet granulation – process vs equipment root cause

Addressing Inconsistencies in FBD Drying During Wet Granulation: Identifying Process and Equipment Failures Inconsistent drying during the Fluid Bed Dryer (FBD) operation can significantly impact the quality of pharmaceutical products,…

Granule attrition issue during wet granulation – inspection risk analysis

Addressing Granule Attrition Issues in Wet Granulation: A Comprehensive Inspection Risk Analysis In pharmaceutical manufacturing, granulation processes play a crucial role in ensuring the quality and efficacy of solid dosage…

Granule attrition issue after scale-up – CAPA and control strategy gap

Addressing Granule Attrition Issues Post Scale-Up in Pharmaceutical Manufacturing Granule attrition following scale-up is a significant challenge in pharmaceutical manufacturing, often leading to product quality issues and regulatory scrutiny. These…

Granule attrition issue during wet granulation – CAPA and control strategy gap

Addressing Granule Attrition Issues During Wet Granulation: A Troubleshooting Guide In the realm of pharmaceutical manufacturing, granulation is a critical process, integral to producing quality solid dosage forms. However, granule…

FBD drying inconsistency after scale-up – CAPA and control strategy gap

Addressing FBD Drying Inconsistencies Post Scale-Up: CAPA and Control Strategy Gaps In the pharmaceutical manufacturing landscape, the scale-up process often presents unique challenges, especially when it comes to equipment performance.…

FBD drying inconsistency during validation – process vs equipment root cause

Addressing Inconsistencies in FBD Drying During Validation: A Comprehensive Problem-Solution Guide Faced with drying inconsistencies during fluidized bed dryer (FBD) validation? This is a critical issue that can compromise product…

Binder spray nozzle blockage during wet granulation – CAPA and control strategy gap

Resolving Binder Spray Nozzle Blockage in Wet Granulation: Strategies and Actions In pharmaceutical manufacturing, maintaining the efficacy and reliability of processing equipment is crucial to ensure quality output. Among the…

Inadequate end-point detection during validation – process vs equipment root cause

Addressing Inadequate End-Point Detection During Validation in Pharmaceutical Equipment Inadequate end-point detection during validation can pose severe risks in pharmaceutical manufacturing processes, particularly in granular equipment such as fluid bed…